top of page

Rubix LS joins the Equity 2030 Alliance

  • maninon0
  • Feb 7
  • 1 min read

The Equity 2030 Alliance is a worldwide initiative aimed at fast-tracking gender equity in science, technology, and finance by 2030.
The Equity 2030 Alliance is a worldwide initiative aimed at fast-tracking gender equity in science, technology, and finance by 2030.


Huge news! Rubix Life Sciences is officially part of the Equity 2030 Alliance!


We’re joining forces with incredible organizations like UNFPA, WHO, USAID, UNAIDS, and PATH to take on some of the biggest challenges in global health equity. It’s an absolute honor to work alongside such inspiring changemakers, and we couldn’t be more excited!


So, what does this mean? It means we’re doubling down on our mission to break down barriers to healthcare access and create a healthier, more equitable future for everyone.


From improving healthcare delivery to driving data equity and expanding access to life-saving care, we’re committed to building solutions that leave no one behind.


Our goal? Equity for ALL by 2030! We’re hopeful about the impact we can achieve together and can’t wait to share updates as this journey unfolds.


Want to learn more? Click here for details: Equity 2030 Alliance

image.png
  • LinkedIn
  • Facebook
  • Twitter
  • Instagram
  • Whatsapp

Rubix LS: We’re the Health Outcomes Architect Company, designing a healthier future for every community.

image.png

Join our mailing list

image.png
image.png

Designing health outcomes for the end in mind
is best for patients & the industries that serve them.

Our mission is to design health outcomes that serve every community by addressing the full range of factors that drive health from biological to environmental to socioeconomic. We are pioneers of holistic, precision-focused approaches that go beyond traditional medicine and looks at deeper systemic factors affecting health and design for that that benefits both patients, the healthcare system, and the industries that support all of it.

Copyright © 2025 Rubix Life Sciences

bottom of page